Finance

Lists
007575:KRX
Ilyang Pharmaceutical Co Ltd Preference Shares
7 480,00 ₩
-0,27%
(-20,00) 1D
19 հոկ, 15:30:00 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 007575...
Open
7 480 ₩
High
7 480 ₩
Low
7 480 ₩
Mkt. cap
142,86 մլրդ
Avg. vol.
426,00
Volume
11,00
Dividend
2,07%
Quarterly dividend
39 ₩
Ex-dividend date
27 դեկ, 2023 թ.
P/E ratio
7,57
52-wk high
15 260 ₩
52-wk low
6 350 ₩
EPS
988 ₩
Shares outstanding
445,08 հզր
No. of employees
660
Open
7 480 ₩
High
7 480 ₩
Low
7 480 ₩
Mkt. cap
142,86 մլրդ
Avg. vol.
426,00
Volume
11,00
Dividend
2,07%
Quarterly dividend
39 ₩
Ex-dividend date
27 դեկ, 2023 թ.
P/E ratio
7,57
52-wk high
15 260 ₩
52-wk low
6 350 ₩
EPS
988 ₩
Shares outstanding
445,08 հզր
No. of employees
660
News stories
From web sources and news partners
About Ilyang Pharmaceutical Co Ltd Preference Shares
CEOKim Dong-yeon
Employees660
Founded01 հլս, 1946 թ.
Headquarters-
Sector-
Websitehome.ilyang.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
68,83 մլրդ
78,91 մլրդ
65,07 մլրդ
65,14 մլրդ
Cost of goods sold
41,32 մլրդ
45,42 մլրդ
40,63 մլրդ
40,74 մլրդ
Cost of revenue
41,32 մլրդ
45,42 մլրդ
40,63 մլրդ
40,74 մլրդ
Research and development expenses
7,01 մլրդ
7,00 մլրդ
8,87 մլրդ
5,94 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,76 մլրդ
24,92 մլրդ
22,29 մլրդ
22,34 մլրդ
Operating expense
27,66 մլրդ
32,93 մլրդ
31,82 մլրդ
31,17 մլրդ
Total operating expenses
68,98 մլրդ
78,35 մլրդ
72,44 մլրդ
71,91 մլրդ
Operating income
-157,75 մլն
565,93 մլն
-7,37 մլրդ
-6,77 մլրդ
Other non operating income
11,87 մլրդ
-681,30 մլն
24,70 մլրդ
2,24 մլրդ
EBT including unusual items
11,42 մլրդ
-1,72 մլրդ
17,95 մլրդ
-5,08 մլրդ
EBT excluding unusual items
11,35 մլրդ
-1,72 մլրդ
17,62 մլրդ
-5,06 մլրդ
Income tax expense
3,04 մլրդ
3,92 մլրդ
983,97 մլն
-2,74 մլրդ
Effective tax rate
26,58%
-227,04%
5,48%
53,89%
Other operating expenses
639,84 մլն
573,32 մլն
453,35 մլն
433,71 մլն
Net income
8,44 մլրդ
-5,65 մլրդ
16,80 մլրդ
-2,29 մլրդ
Net profit margin
12,26%
-7,16%
25,81%
-3,52%
Earnings per share
-
-
-
-
Interest and investment income
-
184,97 մլն
140,72 մլն
144,16 մլն
Interest expense
-
-738,07 մլն
-711,18 մլն
-702,63 մլն
Net interest expenses
-
-553,10 մլն
-570,46 մլն
-558,47 մլն
Depreciation and amortization charges
212,18 մլն
210,49 մլն
211,82 մլն
220,64 մլն
EBITDA
1,93 մլրդ
2,65 մլրդ
-5,30 մլրդ
-4,54 մլրդ
Gain or loss from assets sale
-71,72 մլն
6,86 հզր
-
31,87 մլն
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps